Skip to main content
Log in

The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging

  • Gynecologic Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Objective

The aim of this study was to investigate the value of [18F]fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in predicting lymph node status in node-negative endometrial cancer on preoperative magnetic resonance imaging (MRI).

Methods

Patients with endometrial cancer who underwent both preoperative MRI and FDG-PET/CT followed by hysterectomy and lymphadenectomy were initially included. We then enrolled patients with MRI-defined node-negative disease (lymph nodes <1 cm in the short-axis diameter, or no visible lymph node). Histologic examination was the gold standard for lymph node metastasis diagnosis. The diagnostic performance of FDG-PET/CT in predicting lymph node metastasis was calculated in patient-by-patient and lymph node station-by-station analyses.

Results

On preoperative MRI, 362 patients had no lymph node metastasis. All patients underwent pelvic lymph node dissection and 118 patients underwent further para-aortic lymph node dissection. From 2099 lymph node stations, 10,238 lymph nodes were retrieved. Twenty-seven patients (7.5%) had lymph node metastasis in 49 lymph node stations (2.3%) on pathologic examination. FDG-PET/CT identified lymph node metastasis in five patients (18.5%) and eight lymph node stations (16.3%). The median diameter of false-negative metastatic lymph nodes was 6 mm (range 1–22) in the long axis and 3 mm (range 1–11) in the short axis. For para-aortic lymph nodes, FDG-PET/CT diagnosed 2 of 11 patients (18.1%) with para-aortic lymph node metastasis, and 3 of 12 para-aortic lymph node stations (25%) with metastasis.

Conclusion

Preoperative FDG-PET/CT has low value in predicting lymph node metastasis in node-negative endometrial cancer on preoperative MRI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Green CS, Kattner F, Siegel MH, et al. Differences in perceptual learning transfer as a function of training task. J Vis 2015; 15:5.

    Article  PubMed  Google Scholar 

  2. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136:E359–86.

    Article  CAS  PubMed  Google Scholar 

  3. Jung KW, Won YJ, Oh CM, et al. Prediction of cancer incidence and mortality in Korea, 2015. Cancer Res Treat 2015; 47:142–8.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Huang CY, Chen CA, Chen YL, et al. Nationwide surveillance in uterine cancer: survival analysis and the importance of birth cohort: 30-year population-based registry in Taiwan. PLoS One 2012; 7:e51372.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ushijima K. Current status of gynecologic cancer in Japan. J Gynecol Oncol 2009; 20:67–71.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Morice P, Leary A, Creutzberg C, et al. Endometrial cancer. Lancet 2016;387(10023):1094–1108.

    Article  PubMed  Google Scholar 

  7. ASTEC Study Group, Kitchener H, Swart AM, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009; 373:125–36.

    Article  Google Scholar 

  8. Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008; 100:1707–16.

    Article  PubMed  Google Scholar 

  9. May K, Bryant A, Dickinson HO, et al. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev 2010;(1):CD007585.

  10. Choi HJ, Roh JW, Seo SS, et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer 2006; 106:914–22.

    Article  PubMed  Google Scholar 

  11. Manfredi R, Mirk P, Maresca G, et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 2004; 231:372–8.

    Article  PubMed  Google Scholar 

  12. Chang MC, Chen JH, Liang JA, et al. 18F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer: a systematic review and meta-analysis. Eur J Radiol 2012; 81:3511–7.

    Article  PubMed  Google Scholar 

  13. Park JY, Kim EN, Kim DY, et al. Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol Oncol 2008; 108:486–92.

    Article  PubMed  Google Scholar 

  14. Kim HJ, Cho A, Yun M, et al. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer. Ann Nucl Med 2016; 30:104–13.

    Article  PubMed  Google Scholar 

  15. Lee SI, Catalano OA, Dehdashti F. Evaluation of gynecologic cancer with MR imaging, 18F-FDG PET/CT, and PET/MR imaging. J Nucl Med 2015; 56:436–43.

    Article  PubMed  Google Scholar 

  16. Bollineni VR, Ytre-Hauge S, Bollineni-Balabay O, et al. High diagnostic value of FDG-PET/CT in endometrial cancer: Systematic review and meta-analysis of the literature. J Nucl Med 2016;57(6):879–85.

    Article  PubMed  Google Scholar 

  17. Chou HH, Chang TC, Yen TC, et al. Low value of [18F]-fluoro-2-deoxy-d-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy. J Clin Oncol 2006; 24:123–8.

    Article  PubMed  Google Scholar 

  18. Outwater E, Kressel HY. Evaluation of gynecologic malignancy by magnetic resonance imaging. Radiol Clin North Am 1992; 30:789–806.

    CAS  PubMed  Google Scholar 

  19. Kim SH, Kim SC, Choi BI, et al. Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. Radiology 1994; 190:807–11.

    Article  CAS  PubMed  Google Scholar 

  20. Choi HJ, Kim SH, Seo SS, et al. MRI for pretreatment lymph node staging in uterine cervical cancer. AJR Am J Roentgenol 2006; 187:W538–43.

    Article  PubMed  Google Scholar 

  21. Togashi K, Nishimura K, Sagoh T, et al. Carcinoma of the cervix: staging with MR imaging. Radiology 1989; 171:245–51.

    Article  CAS  PubMed  Google Scholar 

  22. Yu KK, Hricak H, Subak LL, et al. Preoperative staging of cervical carcinoma: phased array coil fast spin-echo versus body coil spin-echo T2-weighted MR imaging. AJR Am J Roentgenol 1998; 171:707–11.

    Article  CAS  PubMed  Google Scholar 

  23. Yang WT, Lam WW, Yu MY, et al. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR Am J Roentgenol 2000; 175:759–66.

    Article  CAS  PubMed  Google Scholar 

  24. Paley PJ, Veljovich DS, Press J, et al. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging. Am J Obstet Gynecol 2016;215(1):117.e1–7.

  25. Rossi EC, Kowalski LD, Scalici J, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 2017; 18:384–92.

    Article  PubMed  Google Scholar 

  26. Queiroz MA, Kubik-Huch RA, Hauser N, et al. PET/MRI and PET/CT in advanced gynaecological tumours: initial experience and comparison. Eur Radiol 2015; 25:2222–30.

    Article  PubMed  Google Scholar 

  27. Kitajima K, Suenaga Y, Ueno Y, et al. Value of fusion of PET and MRI for staging of endometrial cancer: comparison with (1)(8)F-FDG contrast-enhanced PET/CT and dynamic contrast-enhanced pelvic MRI. Eur J Radiol 2013; 82:1672–6.

    Article  PubMed  Google Scholar 

Download references

Disclosures

Jeong-Yeol Park, Jong Jin Lee, Hyuck Jae Choi, In Hye Song, Chang Ohk Sung, Hye Ok Kim, Sun-Young Chae, Young-Tak Kim, and Joo-Hyun Nam declare that there are no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jeong-Yeol Park MD, PhD or Hyuck Jae Choi MD, PhD.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 12 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, JY., Lee, J.J., Choi, H.J. et al. The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging. Ann Surg Oncol 24, 2303–2310 (2017). https://doi.org/10.1245/s10434-017-5901-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-017-5901-8

Keywords

Navigation